IDEAYA Biosciences, Inc.
IDYA· Nasdaq
Filed Aug 12, 2019 · 10-Q · 43 days after period end · 0001564590-19-031477
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Net Income | -$10.66M | -$7.00M |
| EPS Diluted | -$1.30 | -$7.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 12, 2019 · 43 d after period end